Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Doblin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Psychoactive Drugs|April 15, 2003
A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDARick Doblin
Journal of Psychoactive Drugs|May 17, 2014
History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS)Amy Emerson, Linnae Ponté, Lisa Jerome, et al.
Journal of Psychoactive Drugs|August 19, 2021
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory SurveyBrian S Barnett, Yvan Beaussant, Franklin King, et al.
Plos One|October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSDElliot Marseille, James G Kahn, Berra Yazar-Klosinski, et al.
Journal of Psychopharmacology (Oxford, England)|August 16, 2022
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level dataBrian S Barnett, Kathleen Ziegler, Rick Doblin, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Journal of Psychoactive Drugs|November 14, 2008
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorderJosé Carlos Bouso, Rick Doblin, Magí Farré, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Psychoactive Drugs|April 15, 2003
A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDARick Doblin
Journal of Psychoactive Drugs|May 17, 2014
History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS)Amy Emerson, Linnae Ponté, Lisa Jerome, et al.
Journal of Psychoactive Drugs|August 19, 2021
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory SurveyBrian S Barnett, Yvan Beaussant, Franklin King, et al.
Plos One|October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSDElliot Marseille, James G Kahn, Berra Yazar-Klosinski, et al.
Journal of Psychopharmacology (Oxford, England)|August 16, 2022
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level dataBrian S Barnett, Kathleen Ziegler, Rick Doblin, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Journal of Psychoactive Drugs|November 14, 2008
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorderJosé Carlos Bouso, Rick Doblin, Magí Farré, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Pageof 4